1e
19
1
49
2
2
18
1b
1d
18
3b
39
1d
2 29
1d
25
Philip A. Rea, D.Phil., D.Sc.
77
39
Professor of Biology
28
85
3
5e
Rebecka and Arie Belldegrun Distinguished Director, College of Arts & Sciences
11
Department: Biology
4
1
b
1d
46
Contact information
43
4
3
3
1d
43
Department of Biology
22 University of Pennsylvania
3e 110 Neural and Behavioral Sciences Building, Suite 101
3e 425 South University Avenue
Philadelphia, PA 19104
26
22 University of Pennsylvania
3e 110 Neural and Behavioral Sciences Building, Suite 101
3e 425 South University Avenue
Philadelphia, PA 19104
30
Office: (215) 573-1429
34 Fax: (215) 898-8780
24
87
34 Fax: (215) 898-8780
24
Email:
parea@sas.upenn.edu
12
parea@sas.upenn.edu
18
Publications
23 a
3
2
29
23 a
Links
157 Search PubMed for articles
38 Roy and Diana Vagelos Program in Life Sciences & Management
3b Department of Biology Faculty Webpage
c
4
b
1f
157 Search PubMed for articles
38 Roy and Diana Vagelos Program in Life Sciences & Management
3b Department of Biology Faculty Webpage
c
13
Education:
21 f B.Sc. Hons 14 (Biology) c
31 University of Sussex, UK, 1978.
21 c D.Phil. 1f (Plant Biochemistry) c
31 University of Oxford, UK, 1982.
21 a D.Sc. 1b (Plant Sciences) c
43 Magdalen College, University of Oxford, UK, 2020.
c
3
3
3
3
8b
Permanent link21 f B.Sc. Hons 14 (Biology) c
31 University of Sussex, UK, 1978.
21 c D.Phil. 1f (Plant Biochemistry) c
31 University of Oxford, UK, 1982.
21 a D.Sc. 1b (Plant Sciences) c
43 Magdalen College, University of Oxford, UK, 2020.
c
2 29
21
1e
1d
24
5e
8
3e7 Our primary research activities centered on the molecular biology, cellular biochemistry and proteomics of vacuolar function with special emphasis on membrane transport proteins and the enzymic machinery responsible for the detoxification of xenobiotics, including heavy metals. Long-term objectives are to identify the proteins concerned and elucidate their mechanisms of action and regulatory characteristics. Our approach has been that of the 'basic biologist' - the search for general principles, not just principles applicable to plants. Most of our studies therefore entailed parallel molecular and biochemical manipulations of several model systems including the plant Arabidopsis thaliana, the yeast Saccharomyces cerevisiae and the worm Caenorhabditis elegans. It is through the application of this approach that we have been able to make fundamental contributions toward understanding a remarkably broad range of transport and related phenomena of general relevance. These include:
8
90 (1) ABC transporters - Identification and molecular characterization of glutathione S-conjugate pumps (GS-X pumps) in yeast and plants.
8
116 (2) Phytochelatin-dependent heavy metal detoxification - Molecular cloning, in vitro reconstitution, and elucidation of catalytic mechanism of the enzyme phytochelatin (PC) synthase responsible for the fabrication of short-chain metal-binding peptides from glutathione.
8
d6 (3) Pyrophosphate-energized proton pumps - Elucidation of the basic organization and core catalytic capabilities of proton-translocating inorganic pyrophosphatases (V-PPases), a novel class of proton pump.
8
1e6 (4) Vacuolar proteomics - Elucidation of the protein profile of the yeast vacuole using high-purity ‘proteomics-grade’ intact vacuoles. In strict agreement with a predominantly lysosomal function for this organelle, most of the proteins identified are either canonical vacuolar proteases or proteins involved in intermediary metabolism, protein synthesis, folding or targeting, or the alleviation of oxidative stress that have entered this compartment for salvage purposes.
8
2b Secondary research: science writing
8
1b1 At the time of writing, our research at the interface of the life sciences and their implementation focuses on case studies that highlight the difficult transition from discovery in the laboratory to success in the market and/or toward the expansion of humanitarian efforts. Our research centers on case studies that reveal how unexpected discoveries lead to significant advances in medicine, agriculture, and public health.
8
a10 Our six feature articles, written for the educated layperson and translated into several languages, each focus on a different example of this transition. In ‘Statins: From Fungus to Pharma,’ we examine how a discovery reminiscent of the penicillin breakthrough transformed our understanding of cardiovascular disease and led to the development of statins, one of the twentieth century’s most notable biomedical achievements. In ‘Ivermectin and River Blindness,’ we highlight the global health challenge of river blindness – a disease that remains obscure to many in the developed world. This article draws a surprising connection between the disease and the deworming tablets commonly used to protect pets and livestock, emphasizing the hidden links between veterinary and human medicine. The article ‘Can Skinny Fat Beat Obesity?’ presents an up-to-date account of recent discoveries regarding brown and beige fat. These fat types help counteract the harmful effects of excess white fat – a major contributor to cardiovascular disease, type 2 diabetes, and metabolic syndrome. This piece is of general interest to anyone concerned about obesity, offering insights into how these discoveries might pave the way for new therapeutic approaches. In ‘Metformin: Out of Backwaters and Into the Mainstream,’ we trace the intriguing and sometimes circuitous history of metformin. Once shrouded in folklore and uncertainty, this drug has become the standard treatment for type 2 diabetes despite its relatively simple chemical structure and a mechanism of action that remained elusive until recently. Similarly, ‘How Glyphosate Cropped Up’ recounts the remarkable story of glyphosate (better known as Roundup), the most widely used herbicide in the world. The article explains how this herbicide was accidentally discovered as a modified amino acid and how its finely tuned structure enables it to disrupt a key enzyme in the shikimate pathway, a pathway vital for plant life. Our most recent feature, ‘Gliflozins for Diabetes: From Bark to Bench to Bedside,’ explores a new class of drugs that target the kidneys to treat diabetes. These gliflozins provide unprecedented cardiorenal benefits and are the culmination of nearly two centuries of research that began with an uprooted apple orchard Each article not only highlights a unique journey in life sciences research but also demonstrates the unexpected paths and serendipitous events that frequently contribute to significant advancements in the life sciences and public health.
8
289 An extension of these research activities is the book Managing Discovery in the Life Sciences. Harnessing Creativity to Drive Biomedical Innovation (2018), Cambridge University Press). In this book, co-authored with Mark V. Pauly and Lawton R. Burns, case studies of biomedical innovations are presented whereby the reader comes to better understand how the science actually played out through the interplay of personalities and cultures within and between academic and corporate entities and the significance of serendipity not as a mysterious phenomenon but one that is intrinsic to the successes and failures of the experimental approach.
6e
e 29
27
Description of Research Expertise
63 Primary research: energy-dependent transport and cellular detoxification processes8
3e7 Our primary research activities centered on the molecular biology, cellular biochemistry and proteomics of vacuolar function with special emphasis on membrane transport proteins and the enzymic machinery responsible for the detoxification of xenobiotics, including heavy metals. Long-term objectives are to identify the proteins concerned and elucidate their mechanisms of action and regulatory characteristics. Our approach has been that of the 'basic biologist' - the search for general principles, not just principles applicable to plants. Most of our studies therefore entailed parallel molecular and biochemical manipulations of several model systems including the plant Arabidopsis thaliana, the yeast Saccharomyces cerevisiae and the worm Caenorhabditis elegans. It is through the application of this approach that we have been able to make fundamental contributions toward understanding a remarkably broad range of transport and related phenomena of general relevance. These include:
8
90 (1) ABC transporters - Identification and molecular characterization of glutathione S-conjugate pumps (GS-X pumps) in yeast and plants.
8
116 (2) Phytochelatin-dependent heavy metal detoxification - Molecular cloning, in vitro reconstitution, and elucidation of catalytic mechanism of the enzyme phytochelatin (PC) synthase responsible for the fabrication of short-chain metal-binding peptides from glutathione.
8
d6 (3) Pyrophosphate-energized proton pumps - Elucidation of the basic organization and core catalytic capabilities of proton-translocating inorganic pyrophosphatases (V-PPases), a novel class of proton pump.
8
1e6 (4) Vacuolar proteomics - Elucidation of the protein profile of the yeast vacuole using high-purity ‘proteomics-grade’ intact vacuoles. In strict agreement with a predominantly lysosomal function for this organelle, most of the proteins identified are either canonical vacuolar proteases or proteins involved in intermediary metabolism, protein synthesis, folding or targeting, or the alleviation of oxidative stress that have entered this compartment for salvage purposes.
8
2b Secondary research: science writing
8
1b1 At the time of writing, our research at the interface of the life sciences and their implementation focuses on case studies that highlight the difficult transition from discovery in the laboratory to success in the market and/or toward the expansion of humanitarian efforts. Our research centers on case studies that reveal how unexpected discoveries lead to significant advances in medicine, agriculture, and public health.
8
a10 Our six feature articles, written for the educated layperson and translated into several languages, each focus on a different example of this transition. In ‘Statins: From Fungus to Pharma,’ we examine how a discovery reminiscent of the penicillin breakthrough transformed our understanding of cardiovascular disease and led to the development of statins, one of the twentieth century’s most notable biomedical achievements. In ‘Ivermectin and River Blindness,’ we highlight the global health challenge of river blindness – a disease that remains obscure to many in the developed world. This article draws a surprising connection between the disease and the deworming tablets commonly used to protect pets and livestock, emphasizing the hidden links between veterinary and human medicine. The article ‘Can Skinny Fat Beat Obesity?’ presents an up-to-date account of recent discoveries regarding brown and beige fat. These fat types help counteract the harmful effects of excess white fat – a major contributor to cardiovascular disease, type 2 diabetes, and metabolic syndrome. This piece is of general interest to anyone concerned about obesity, offering insights into how these discoveries might pave the way for new therapeutic approaches. In ‘Metformin: Out of Backwaters and Into the Mainstream,’ we trace the intriguing and sometimes circuitous history of metformin. Once shrouded in folklore and uncertainty, this drug has become the standard treatment for type 2 diabetes despite its relatively simple chemical structure and a mechanism of action that remained elusive until recently. Similarly, ‘How Glyphosate Cropped Up’ recounts the remarkable story of glyphosate (better known as Roundup), the most widely used herbicide in the world. The article explains how this herbicide was accidentally discovered as a modified amino acid and how its finely tuned structure enables it to disrupt a key enzyme in the shikimate pathway, a pathway vital for plant life. Our most recent feature, ‘Gliflozins for Diabetes: From Bark to Bench to Bedside,’ explores a new class of drugs that target the kidneys to treat diabetes. These gliflozins provide unprecedented cardiorenal benefits and are the culmination of nearly two centuries of research that began with an uprooted apple orchard Each article not only highlights a unique journey in life sciences research but also demonstrates the unexpected paths and serendipitous events that frequently contribute to significant advancements in the life sciences and public health.
8
289 An extension of these research activities is the book Managing Discovery in the Life Sciences. Harnessing Creativity to Drive Biomedical Innovation (2018), Cambridge University Press). In this book, co-authored with Mark V. Pauly and Lawton R. Burns, case studies of biomedical innovations are presented whereby the reader comes to better understand how the science actually played out through the interplay of personalities and cultures within and between academic and corporate entities and the significance of serendipity not as a mysterious phenomenon but one that is intrinsic to the successes and failures of the experimental approach.
6e
Description of Other Expertise
83 Co-founding director of the Roy and Diana Vagelos Life Sciences & Management Program. Science writer and educator.e 29
23
95 Rea, P.A.: How glyphosate cropped up. American Scientist 110: 170-177, 2022.
157 Rea, P.A., Pauly, M.V., Burns, L.B.: Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation. ISBN 978-1-107-13090-6 Hardback, ISBN 978-1-107-57730-5 Paperback, 542 pages. Cambridge University Press, Cambridge, United Kingdom, 2018.
be Rea, P.A., Tien, A.Y.: Metformin: out of backwaters and into the mainstream. American Scientist 105: 102-111, 2017.
116 Cahoon, R.E., Lutke, W.K., Cameron, J.C., Chen, S., Lee, S.G., Rivard, R.S., Rea, P.A., Jez, J.M. : Adaptive engineering of phytochelatin-based heavy metal tolerance. J. Biol. Chem. 290: 17321-17330, 2015.
ad Rea, P.A., Yin, P., Zahalka, R.: Can skinny fat beat obesity? American Scientist 102: 272-279, 2014.
bb Rea, P.A.: Phytochelatin synthase: of a protease a peptide polymerase made. Physiol. Plantarum 145: 154-164, 2012.
184 Park, J., Song, W.-J., Mendoza-Cózat, D.G., Suter-Grotemeyer, M., Shim, D., Hörtensteiner, S., Geisler, M., Rea, P.A., Rentsch, D., Schroeder, J.I., Lee, Y., Martinoia, E.: Arsenic tolerance in Arabidopsis is mediated by two ABCC-type phytochelatin transporters. Proc. Natl. Acad. Sci. USA 107: 21187-21192, 2010.
b1 Rea, P.A., Zhang, V., Baras, Y.S.: Ivermectin and river blindness. American Scientist 98: 294-303, 2010.
99 Rea, P.A.: Statins: from fungus to pharma. American Scientist 96: 408-415, 2008.
2c
7
1d
1f
Selected Publications
b2 Rea, P.A.: Gliflozins for diabetes: from bark to bench to bedside. American Scientist 112: 360-367, 2024.95 Rea, P.A.: How glyphosate cropped up. American Scientist 110: 170-177, 2022.
157 Rea, P.A., Pauly, M.V., Burns, L.B.: Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation. ISBN 978-1-107-13090-6 Hardback, ISBN 978-1-107-57730-5 Paperback, 542 pages. Cambridge University Press, Cambridge, United Kingdom, 2018.
be Rea, P.A., Tien, A.Y.: Metformin: out of backwaters and into the mainstream. American Scientist 105: 102-111, 2017.
116 Cahoon, R.E., Lutke, W.K., Cameron, J.C., Chen, S., Lee, S.G., Rivard, R.S., Rea, P.A., Jez, J.M. : Adaptive engineering of phytochelatin-based heavy metal tolerance. J. Biol. Chem. 290: 17321-17330, 2015.
ad Rea, P.A., Yin, P., Zahalka, R.: Can skinny fat beat obesity? American Scientist 102: 272-279, 2014.
bb Rea, P.A.: Phytochelatin synthase: of a protease a peptide polymerase made. Physiol. Plantarum 145: 154-164, 2012.
184 Park, J., Song, W.-J., Mendoza-Cózat, D.G., Suter-Grotemeyer, M., Shim, D., Hörtensteiner, S., Geisler, M., Rea, P.A., Rentsch, D., Schroeder, J.I., Lee, Y., Martinoia, E.: Arsenic tolerance in Arabidopsis is mediated by two ABCC-type phytochelatin transporters. Proc. Natl. Acad. Sci. USA 107: 21187-21192, 2010.
b1 Rea, P.A., Zhang, V., Baras, Y.S.: Ivermectin and river blindness. American Scientist 98: 294-303, 2010.
99 Rea, P.A.: Statins: from fungus to pharma. American Scientist 96: 408-415, 2008.
2c